682.49
Mckesson Corporation (MCK) 最新ニュース
Lobbying Update: $1,220,000 of MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS lobbying was just disclosed - Nasdaq
McKesson Corporation (MCK): One of the Dividend Stocks with Sustainable Payout Ratios - Yahoo Finance
McKesson Careers | The future of health starts with you. - McKesson Careers
Jim Cramer Labels McKesson Corporation (MCK) a “Money Machine – A Must-Own Middleman” - Insider Monkey
McKesson Launches Precision Care Companion for Biomarker-Driven Cancer Care - HIT Consultant
McKesson is medicine for Elite Investors in market chaos - Citywire
Jim Cramer’s List of 16 Stocks to Buy Right Now - Insider Monkey
Citigroup Adjusts Price Target on McKesson to $800 From $685, Maintains Buy Rating - marketscreener.com
McKesson provides Elite Investors with medicine for market choas - Citywire
McKesson (MCK) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
McKesson Launches Collaboration to Boost Precision Oncology Adoption - Inside Precision Medicine
McKesson (NYSE:MCK) Launches Precision Care Initiative Transforming Oncology Treatment - Yahoo Finance
Jim Cramer: McKesson (MCK) Is a “Money Machine” – Funds Keep Flowing In - Yahoo Finance
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology - Business Wire
McKesson Corporation (MCK): Among the Best Value Dividend Stocks to Buy According to Billionaires - Yahoo Finance
3 Dividend Stocks Built for Stability as Growth Trades Cool Off - Investing.com
Middlemen Always Work.” – Jim Cramer’s Love for McKesson Corporation (MCK) - Insider Monkey
GS1 US to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter
GS1 to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter
McKesson (MCK) Sees Price Target Boost to $755 by BofA | CAH Sto - GuruFocus
McKesson To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
McKesson and Wegmans: A Long-Standing Partnership in Advancing Pharmacy - NEWS CHANNEL NEBRASKA
Why the Market Dipped But McKesson (MCK) Gained Today - Yahoo Finance
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know - Yahoo Finance
Jonathan Jackson from Illinois’s 1st district makes notable trades in Microsoft, Salesforce, and McKesson - Investing.com India
This Medical Supplies Distributor Dodges A Tariff Bullet - Investor's Business Daily
Evercore ISI Adjusts Price Target on McKesson to $740 From $675, Maintains Outperform Rating - MarketScreener
McKesson (MCK) Stock Moves -1.38%: What You Should Know - Yahoo Finance
McKesson opens registration for 2025 ideaShare conference - Drug Store News
Registration Opens for Annual McKesson ideaShare Conference - Yahoo Finance
Quad-C Management Completes the Sale of PRISM Vision to McKesson - PR Newswire
Quad-C sells stake in Prism Vision to McKesson Corporation - pehub.com
McKesson Corporation (MCK): Jim Cramer’s Top Pick – Why He Thinks McKesson Can ‘Jack Prices Up’ - Insider Monkey
Zacks Research Brokers Lift Earnings Estimates for McKesson - Defense World
Rite Aid weighs repeat bankruptcy filing, WSJ reports - MarketScreener
McKesson In Huge Group New To IBD 50: Check Out Which Stocks Just Came On – And Off – IBD's Top Stock Screens - Investor's Business Daily
McKesson stock soars to all-time high of $726.13 By Investing.com - Investing.com South Africa
McKesson stock soars to all-time high of $726.13 - Investing.com
Mizuho raises McKesson stock target to $690, maintains neutral By Investing.com - Investing.com South Africa
MCK Stock Gains as PRISM Acquisition Adds High-Growth Business - TradingView
McKesson Corporation completed the acquisition of 80% stake in PRISM Vision Group from Quad-C Management, Inc. - MarketScreener
Deutsche Bank Adjusts Price Target on McKesson to $692 From $700, Maintains Buy Rating - MarketScreener
Mizuho Adjusts Price Target on McKesson to $690 From $630, Maintains Neutral Rating - MarketScreener
McKesson price target raised to $690 from $630 at Mizuho - TipRanks
Mizuho raises McKesson stock target to $690, maintains neutral - Investing.com India
McKesson Shares Up Over 2% After Key Signal - Benzinga
McKesson Gets Drugs to Patients. Buy the Stock for Healthy Returns. - MSN
McKesson (MCK) Poised for Growth in Pharmaceutical Distribution - GuruFocus
Whistleblower Asks Justices to Revive Suit Against McKesson Unit - Bloomberg Law News
大文字化:
|
ボリューム (24 時間):